Cargando…

Patterns of Cognitive Dysfunction in Progressive MS

Background: Progressive MS is associated with a high frequency of cognitive impairment. However, it is not clear to what extent this reflects global dysfunction, or independent deficits in specific functions. Objective: To characterise patterns of cognitive impairment in progressive MS on a multi-di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Connick, Peter, Chandran, Siddharthan, Bak, Thomas H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2013
Materias:	Other
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5215559/ https://www.ncbi.nlm.nih.gov/pubmed/23548884 http://dx.doi.org/10.3233/BEN-120286

Ejemplares similares

The clinico-radiological paradox of cognitive function and MRI burden of white matter lesions in people with multiple sclerosis: A systematic review and meta-analysis
por: Mollison, Daisy, et al.
Publicado: (2017)

A single systemic inflammatory insult causes acute motor deficits and accelerates disease progression in a mouse model of human tauopathy
por: Torvell, Megan, et al.
Publicado: (2019)

Hypothermic Preconditioning of Human Cortical Neurons Requires Proteostatic Priming
por: Rzechorzek, Nina Marie, et al.
Publicado: (2015)

Coupling cognitive and brainstem dysfunction in multiple sclerosis-related chronic neuropathic limb pain
por: Foley, Peter, et al.
Publicado: (2022)

Longitudinal retinal imaging study of newly diagnosed relapsing-remitting multiple sclerosis in Scottish population: baseline and 12 months follow-up profile of FutureMS retinal imaging cohort
por: Chen, Yingdi, et al.
Publicado: (2022)

The Patient Health Questionnaire (PHQ-9) as a tool to screen for depression in people with multiple sclerosis: a cross-sectional validation study
por: Beswick, Emily, et al.
Publicado: (2022)

Executive, language and fluency dysfunction are markers of localised TDP-43 cerebral pathology in non-demented ALS
por: Gregory, Jenna M, et al.
Publicado: (2020)

Optic Neuritis: From Magnocellular to Cognitive Residual Dysfunction
por: Viret, Anne-Claire, et al.
Publicado: (2013)

Cognitive and Emotional Dysfunction after Central Pontine Myelinolysis
por: Lee, Tatia M. C., et al.
Publicado: (2003)

Decision Making Cognition in Primary Progressive Aphasia
por: Gleichgerrcht, Ezequiel, et al.
Publicado: (2012)

Systematic review of prediction models in relapsing remitting multiple sclerosis
por: Brown, Fraser S., et al.
Publicado: (2020)

Drug Repurposing: A Systematic Approach to Evaluate Candidate Oral Neuroprotective Interventions for Secondary Progressive Multiple Sclerosis
por: Vesterinen, Hanna M., et al.
Publicado: (2015)

Olfactory dysfunction in patients with primary progressive MS
por: Schmidt, Felix A., et al.
Publicado: (2017)

Patterns of Dysgraphia in Primary Progressive Aphasia Compared to Post-Stroke Aphasia
por: Faria, Andreia V., et al.
Publicado: (2013)

Efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis (MS-SMART): a phase 2b, multiarm, double-blind, randomised placebo-controlled trial
por: Chataway, Jeremy, et al.
Publicado: (2020)

Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial (MS-SMART): a multiarm phase IIb randomised, double-blind, placebo-controlled clinical trial comparing the efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis
por: Connick, Peter, et al.
Publicado: (2018)

Patterns of brain atrophy in recently-diagnosed relapsing-remitting multiple sclerosis
por: Meijboom, Rozanna, et al.
Publicado: (2023)

Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study
por: Connick, Peter, et al.
Publicado: (2012)

Human Stem Cell-Derived Neurons: A System to Study Human Tau Function and Dysfunction
por: Iovino, Mariangela, et al.
Publicado: (2010)

Immune Dysfunction in Tourette Syndrome
por: Elamin, Ishraga, et al.
Publicado: (2013)

Hypothermic Preconditioning Reverses Tau Ontogenesis in Human Cortical Neurons and is Mimicked by Protein Phosphatase 2A Inhibition
por: Rzechorzek, Nina M., et al.
Publicado: (2015)

FutureMS cohort profile: a Scottish multicentre inception cohort study of relapsing-remitting multiple sclerosis
por: Kearns, Patrick K A, et al.
Publicado: (2022)

A Preliminary Characterisation of Cognition and Social Cognition in Spinocerebellar Ataxia Types 2, 1, and 7
por: Sokolovsky, N., et al.
Publicado: (2010)

Blood-CNS barrier dysfunction in amyotrophic lateral sclerosis: Proposed mechanisms and clinical implications
por: Steinruecke, Moritz, et al.
Publicado: (2023)

Rationale and design of the brain magnetic resonance imaging protocol for FutureMS: a longitudinal multi-centre study of newly diagnosed patients with relapsing-remitting multiple sclerosis in Scotland
por: Meijboom, Rozanna, et al.
Publicado: (2022)

Treatment of Cognitive Impairment in Multiple Sclerosis
por: Pierson, Susan H., et al.
Publicado: (2006)

Progressive inner nuclear layer dysfunction in non-optic neuritis eyes in MS
por: You, Yuyi, et al.
Publicado: (2017)

Improved detection of RNA foci in C9orf72 amyotrophic lateral sclerosis post-mortem tissue using BaseScope™ shows a lack of association with cognitive dysfunction
por: Mehta, Arpan R, et al.
Publicado: (2020)

Remote testing of vitamin D levels across the UK MS population—A case control study
por: Vickaryous, Nicola, et al.
Publicado: (2020)

Cognitive dysfunction in multiple sclerosis: Usually forgotten in the clinical assessment of MS patients
por: Nabavi, Seyed Massood, et al.
Publicado: (2015)

Biomarkers for Risk Stratification of Neoplastic Progression in Barrett Esophagus
por: Kerkhof, Marjon, et al.
Publicado: (2007)

Natalizumab Significantly Improves Cognitive Impairment over Three Years in MS: Pattern of Disability Progression and Preliminary MRI Findings
por: Mattioli, Flavia, et al.
Publicado: (2015)

The Role of DNA Methylation in the Development and Progression of Lung Adenocarcinoma
por: Kerr, Keith M., et al.
Publicado: (2007)

Relevance of Chromatin Features in the Progression of Esophageal Epithelial Severe Dysplasia
por: Gao, Feng, et al.
Publicado: (1997)

Progressive inner nuclear layer dysfunction in non-optic neuritis eyes in MS
Publicado: (2018)

National audit of cognitive assessment in people with pwMND A national audit of cognitive assessment in people with motor neurone disease (pwMND) in Scotland
por: Stavrou, Maria, et al.
Publicado: (2020)

Experimental and Therapeutic Opportunities for Stem Cells in Multiple Sclerosis
por: Patani, Rickie, et al.
Publicado: (2012)

Diagnostic Proteomics: Serum Proteomic Patterns for the Detection of Early Stage Cancers
por: Yu, Li-Rong, et al.
Publicado: (2004)

Lamotrigine-Associated Progressive Dysphasia and Cognitive Dysfunction
por: Brown, Joshua C., et al.
Publicado: (2021)

Real-time associations among MS symptoms and cognitive dysfunction using ecological momentary assessment
por: Chen, Michelle H., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_28lpmed3b95l9ig574imep2u62